Follow
J. Daniel Kelly
J. Daniel Kelly
Assistant Professor, University of California, San Francisco
Verified email at wellbodyalliance.org - Homepage
Title
Cited by
Cited by
Year
Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection
MJ Peluso, S Lu, AF Tang, MS Durstenfeld, H Ho, SA Goldberg, ...
The Journal of infectious diseases 224 (11), 1839-1848, 2021
2122021
ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study
MJ Broadhurst, JD Kelly, A Miller, A Semper, D Bailey, E Groppelli, ...
The Lancet 386 (9996), 867-874, 2015
1892015
Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations
B Sun, N Tang, MJ Peluso, NS Iyer, L Torres, JL Donatelli, SE Munter, ...
Cells 10 (2), 386, 2021
1682021
Prone positioning in moderate to severe acute respiratory distress syndrome due to COVID-19: a cohort study and analysis of physiology
MC Shelhamer, PD Wesson, IL Solari, DL Jensen, WA Steele, ...
Journal of Intensive Care Medicine 36 (2), 241-252, 2021
1632021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ...
Cell Reports 36 (6), 2021
1602021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
J Hellmuth, TA Barnett, BM Asken, JD Kelly, L Torres, ML Stephens, ...
Journal of neurovirology 27, 191-195, 2021
1502021
Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study
JD Kelly, C Hartman, J Graham, MA Kallen, TP Giordano
Journal of the Association of Nurses in AIDS Care 25 (5), 405-413, 2014
1502014
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ...
Science advances 7 (31), eabh3409, 2021
1312021
Biosocial approaches to the 2013-2016 Ebola pandemic
ET Richardson, MB Barrie, JD Kelly, Y Dibba, S Koedoyoma, PE Farmer
Health and human rights 18 (1), 115, 2016
1072016
Strengthening health systems while responding to a health crisis: lessons learned by a nongovernmental organization during the Ebola virus disease epidemic in Sierra Leone
C Cancedda, SM Davis, KL Dierberg, J Lascher, JD Kelly, MB Barrie, ...
The Journal of infectious diseases 214 (suppl_3), S153-S163, 2016
1022016
Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in Sierra Leone: a field evaluation study
AE Semper, MJ Broadhurst, J Richards, GM Foster, AJH Simpson, ...
PLoS medicine 13 (3), e1001980, 2016
992016
Community trust and the Ebola endgame
RS Dhillon, JD Kelly
New England Journal of Medicine 373 (9), 787-789, 2015
972015
Chronic viral coinfections differentially affect the likelihood of developing long COVID
MJ Peluso, TM Deveau, SE Munter, D Ryder, A Buck, G Beck-Engeser, ...
The Journal of clinical investigation 133 (3), 2023
912023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
DG Augusto, LD Murdolo, DSM Chatzileontiadou, JJ Sabatino Jr, ...
Nature 620 (7972), 128-136, 2023
822023
SARS‐CoV‐2 and mitochondrial proteins in neural‐derived exosomes of COVID‐19
MJ Peluso, SG Deeks, M Mustapic, D Kapogiannis, TJ Henrich, S Lu, ...
Annals of neurology 91 (6), 772-781, 2022
772022
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19
AC Apple, A Oddi, MJ Peluso, BM Asken, TJ Henrich, JD Kelly, ...
Annals of clinical and translational neurology 9 (2), 221-226, 2022
692022
Minimally symptomatic infection in an Ebola ‘hotspot’: a cross-sectional serosurvey
ET Richardson, JD Kelly, MB Barrie, AW Mesman, S Karku, K Quiwa, ...
PLoS neglected tropical diseases 10 (11), e0005087, 2016
692016
Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement
MJ Peluso, JD Kelly, S Lu, SA Goldberg, MC Davidson, S Mathur, ...
Open forum infectious diseases 9 (2), ofab640, 2022
652022
Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection
MJ Peluso, HM Sans, CA Forman, AN Nylander, H Ho, S Lu, SA Goldberg, ...
Neurology: Neuroimmunology & Neuroinflammation 9 (5), e200003, 2022
582022
Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies
MJ Peluso, K Anglin, MS Durstenfeld, JN Martin, JD Kelly, PY Hsue, ...
Pathogens and Immunity 7 (1), 95, 2022
562022
The system can't perform the operation now. Try again later.
Articles 1–20